1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549-1004 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): DECEMBER 26, 2000 CARDIAC PATHWAYS CORPORATION (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) DELAWARE 000-28372 77-0278793 (STATE OR OTHER JURISDICTION OF [COMMISSION FILE NUMBER] (I.R.S. EMPLOYER INCORPORATION OR ORGANIZATION) IDENTIFICATION NUMBER) 995 BENECIA AVENUE SUNNYVALE, CA 94085 (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (408) 737-0505 (REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE) 2 ITEM 5. OTHER EVENTS On December 26, 2000, Cardiac Pathways Corporation issued a press release announcing that it had closed a common stock financing. The press release is attached as Exhibit 99.1 to this Form 8-K. ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS (c) Exhibits. EXHIBIT NUMBER DESCRIPTION 99.1 Cardiac Pathways Corporation Press Release issued December 26, 2000. 3 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CARDIAC PATHWAYS CORPORATION (Registrant) Date: December 26, 2000 By: /s/ Thomas M. Prescott --------------------------- Thomas M. Prescott President and Chief Executive Officer -2- 4 EXHIBIT INDEX EXHIBIT NUMBER DESCRIPTION 99.1 Cardiac Pathways Corporation Press Release issued December 26, 2000. -3-